메뉴 건너뛰기




Volumn 169, Issue 2, 2013, Pages 337-352

Minocycline: Far beyond an antibiotic

Author keywords

anti inflammatory; antibiotic; immunomodulatory; minocycline; neuroprotection; tetracyclines

Indexed keywords

MINOCYCLINE; PLACEBO;

EID: 84876893112     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12139     Document Type: Review
Times cited : (730)

References (181)
  • 1
    • 60549113797 scopus 로고    scopus 로고
    • Drugs used to treat Parkinson's disease, present status and future directions
    • Abdel-Salam OME, (2008). Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets 7: 321-342.
    • (2008) CNS Neurol Disord Drug Targets , vol.7 , pp. 321-342
    • Abdel-Salam, O.M.E.1
  • 2
    • 33748057491 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
    • Agwuh KN, MacGowan A, (2006). Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58: 256-265.
    • (2006) J Antimicrob Chemother , vol.58 , pp. 256-265
    • Agwuh, K.N.1    Macgowan, A.2
  • 3
    • 33745457705 scopus 로고    scopus 로고
    • Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations
    • Alano CC, Kauppinen TM, Valls AV, Swanson RA, (2006). Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A 103: 9685-9690.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 9685-9690
    • Alano, C.C.1    Kauppinen, T.M.2    Valls, A.V.3    Swanson, R.A.4
  • 4
    • 0030832313 scopus 로고    scopus 로고
    • Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines
    • Amin AR, Patel RN, Thakker GD, Lowenstein CJ, Attur MG, Abramson SB, (1997). Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett 410: 259-264.
    • (1997) FEBS Lett , vol.410 , pp. 259-264
    • Amin, A.R.1    Patel, R.N.2    Thakker, G.D.3    Lowenstein, C.J.4    Attur, M.G.5    Abramson, S.B.6
  • 6
    • 0019292911 scopus 로고
    • Pharmacotherapeutics of the newer tetracyclines
    • Aronson AL, (1980). Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 176: 1061-1068.
    • (1980) J Am Vet Med Assoc , vol.176 , pp. 1061-1068
    • Aronson, A.L.1
  • 7
    • 0027014341 scopus 로고
    • Tetracyclines (TETs) inhibit the synthesis and/or activity of cartilage proteinases in vivo and in vitro
    • Arsenis C, Moak SA, Greenwald RA, (1992). Tetracyclines (TETs) inhibit the synthesis and/or activity of cartilage proteinases in vivo and in vitro. Matrix Suppl 1: 314.
    • (1992) Matrix Suppl , vol.1 , pp. 314
    • Arsenis, C.1    Moak, S.A.2    Greenwald, R.A.3
  • 9
    • 0030826591 scopus 로고    scopus 로고
    • Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats
    • Bain S, Ramamurthy NS, Impeduglia T, Scolman S, Golub LM, Rubin C, (1997). Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone 21: 147-153.
    • (1997) Bone , vol.21 , pp. 147-153
    • Bain, S.1    Ramamurthy, N.S.2    Impeduglia, T.3    Scolman, S.4    Golub, L.M.5    Rubin, C.6
  • 10
    • 0016746179 scopus 로고
    • Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs
    • Barza M, Brown RB, Shanks C, Gamble C, Weinstein L, (1975). Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother 8: 713-720.
    • (1975) Antimicrob Agents Chemother , vol.8 , pp. 713-720
    • Barza, M.1    Brown, R.B.2    Shanks, C.3    Gamble, C.4    Weinstein, L.5
  • 11
    • 79955788939 scopus 로고    scopus 로고
    • Clinical and biochemical efficacy of minocycline in nonsurgical periodontal therapy: A randomized controlled pilot study
    • Basegmez C, Berber L, Yalcin F, (2011). Clinical and biochemical efficacy of minocycline in nonsurgical periodontal therapy: a randomized controlled pilot study. J Clin Pharmacol 51: 915-922.
    • (2011) J Clin Pharmacol , vol.51 , pp. 915-922
    • Basegmez, C.1    Berber, L.2    Yalcin, F.3
  • 12
    • 62149089881 scopus 로고    scopus 로고
    • Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model
    • Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW, et al. (2009). Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46: 94-102.
    • (2009) J Med Genet , vol.46 , pp. 94-102
    • Bilousova, T.V.1    Dansie, L.2    Ngo, M.3    Aye, J.4    Charles, J.R.5    Ethell, D.W.6
  • 14
    • 0016680814 scopus 로고
    • Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use
    • Brogden RN, Speight TM, Avery GS, (1975). Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 9: 251-291.
    • (1975) Drugs , vol.9 , pp. 251-291
    • Brogden, R.N.1    Speight, T.M.2    Avery, G.S.3
  • 15
    • 0036260089 scopus 로고    scopus 로고
    • Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis
    • Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW, (2002). Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125: 1297-1308.
    • (2002) Brain , vol.125 , pp. 1297-1308
    • Brundula, V.1    Rewcastle, N.B.2    Metz, L.M.3    Bernard, C.C.4    Yong, V.W.5
  • 16
    • 79955941855 scopus 로고    scopus 로고
    • Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation
    • Cai Z, Zhao Y, Yao S, Bin Zhao B, (2011). Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation. Pharmacol Rep 63: 381-391.
    • (2011) Pharmacol Rep , vol.63 , pp. 381-391
    • Cai, Z.1    Zhao, Y.2    Yao, S.3    Bin Zhao, B.4
  • 18
    • 0042521291 scopus 로고    scopus 로고
    • Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins
    • Chen A, Muzzio IA, Malleret G, Bartsch D, Verbitsky M, Pavlidis P, et al. (2003). Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 39: 655-669.
    • (2003) Neuron , vol.39 , pp. 655-669
    • Chen, A.1    Muzzio, I.A.2    Malleret, G.3    Bartsch, D.4    Verbitsky, M.5    Pavlidis, P.6
  • 19
    • 0033912716 scopus 로고    scopus 로고
    • Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
    • Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, et al. (2000). Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6: 797-801.
    • (2000) Nat Med , vol.6 , pp. 797-801
    • Chen, M.1    Ona, V.O.2    Li, M.3    Ferrante, R.J.4    Fink, K.B.5    Zhu, S.6
  • 20
    • 79955425304 scopus 로고    scopus 로고
    • The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury
    • Cho DC, Cheong JH, Yang MS, Hwang SJ, Kim JM, Kim CH, (2011). The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury. J Korean Neurosurg Soc 49: 83-91.
    • (2011) J Korean Neurosurg Soc , vol.49 , pp. 83-91
    • Cho, D.C.1    Cheong, J.H.2    Yang, M.S.3    Hwang, S.J.4    Kim, J.M.5    Kim, C.H.6
  • 21
    • 35348819417 scopus 로고    scopus 로고
    • Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models
    • Choi Y, Kim H-S, Shin KY, Kim E-M, Kim M, Kim H-S, et al. (2007). Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32: 2393-2404.
    • (2007) Neuropsychopharmacology , vol.32 , pp. 2393-2404
    • Choi, Y.1    Kim, H.-S.2    Shin, K.Y.3    Kim, E.-M.4    Kim, M.5    Kim, H.-S.6
  • 22
    • 0032978701 scopus 로고    scopus 로고
    • The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior
    • Colburn RW, Rickman AJ, DeLeo JA, (1999). The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157: 289-304.
    • (1999) Exp Neurol , vol.157 , pp. 289-304
    • Colburn, R.W.1    Rickman, A.J.2    Deleo, J.A.3
  • 23
    • 6944253634 scopus 로고    scopus 로고
    • Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures
    • Corbacella E, Lanzoni I, Ding D, Previati M, Salvi R, (2004). Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures. Hear Res 197: 11-18.
    • (2004) Hear Res , vol.197 , pp. 11-18
    • Corbacella, E.1    Lanzoni, I.2    Ding, D.3    Previati, M.4    Salvi, R.5
  • 24
    • 76749139924 scopus 로고    scopus 로고
    • Early-stage inflammation and experimental therapy in transgenic models of the Alzheimer-like amyloid pathology
    • Cuello AC, Ferretti MT, Leon WC, Iulita MF, Melis T, Ducatenzeiler A, et al. (2010). Early-stage inflammation and experimental therapy in transgenic models of the Alzheimer-like amyloid pathology. Neurodegener Dis 7: 96-98.
    • (2010) Neurodegener Dis , vol.7 , pp. 96-98
    • Cuello, A.C.1    Ferretti, M.T.2    Leon, W.C.3    Iulita, M.F.4    Melis, T.5    Ducatenzeiler, A.6
  • 26
    • 3042818738 scopus 로고    scopus 로고
    • Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease
    • Diguet E, Rouland R, Tison F, (2003). Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease. Ann Neurol 54: 841-842.
    • (2003) Ann Neurol , vol.54 , pp. 841-842
    • Diguet, E.1    Rouland, R.2    Tison, F.3
  • 27
    • 3042755065 scopus 로고    scopus 로고
    • Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
    • Diguet E, Fernagut P-O, Wei X, Du Y, Rouland R, Gross C, et al. (2004a). Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19: 3266-3276.
    • (2004) Eur J Neurosci , vol.19 , pp. 3266-3276
    • Diguet, E.1    Fernagut, P.-O.2    Wei, X.3    Du, Y.4    Rouland, R.5    Gross, C.6
  • 28
    • 3543143700 scopus 로고    scopus 로고
    • Rise and fall of minocycline in neuroprotection: Need to promote publication of negative results
    • Diguet E, Gross CE, Tison F, Bezard E, (2004b). Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Exp Neurol 189: 1-4.
    • (2004) Exp Neurol , vol.189 , pp. 1-4
    • Diguet, E.1    Gross, C.E.2    Tison, F.3    Bezard, E.4
  • 29
    • 7644242460 scopus 로고    scopus 로고
    • Neuroprotection by tetracyclines
    • Domercq M, Matute C, (2004). Neuroprotection by tetracyclines. Trends Pharmacol Sci 25: 609-612.
    • (2004) Trends Pharmacol Sci , vol.25 , pp. 609-612
    • Domercq, M.1    Matute, C.2
  • 30
    • 0035807904 scopus 로고    scopus 로고
    • Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
    • Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, et al. (2001). Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 98: 14669-14674.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 14669-14674
    • Du, Y.1    Ma, Z.2    Lin, S.3    Dodel, R.C.4    Gao, F.5    Bales, K.R.6
  • 31
    • 0018084723 scopus 로고
    • The effect of antimicrobial agents on leukocyte chemotaxis
    • Esterly NB, Furey NL, Flanagan LE, (1978). The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 70: 51-55.
    • (1978) J Invest Dermatol , vol.70 , pp. 51-55
    • Esterly, N.B.1    Furey, N.L.2    Flanagan, L.E.3
  • 32
    • 0021160015 scopus 로고
    • Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy
    • Esterly NB, Koransky JS, Furey NL, Trevisan M, (1984). Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 120: 1308-1313.
    • (1984) Arch Dermatol , vol.120 , pp. 1308-1313
    • Esterly, N.B.1    Koransky, J.S.2    Furey, N.L.3    Trevisan, M.4
  • 33
    • 33646598662 scopus 로고    scopus 로고
    • Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury
    • Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS, Citron BA, (2006). Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 97: 1314-1326.
    • (2006) J Neurochem , vol.97 , pp. 1314-1326
    • Festoff, B.W.1    Ameenuddin, S.2    Arnold, P.M.3    Wong, A.4    Santacruz, K.S.5    Citron, B.A.6
  • 34
    • 0030775862 scopus 로고    scopus 로고
    • Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets
    • Feuerstein GZ, Wang X, Barone FC, (1997). Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann N Y Acad Sci 825: 179-193.
    • (1997) Ann N y Acad Sci , vol.825 , pp. 179-193
    • Feuerstein, G.Z.1    Wang, X.2    Barone, F.C.3
  • 35
    • 57049162390 scopus 로고    scopus 로고
    • Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: Inhibition of apoptosis signal-regulating kinase 1
    • Follstaedt SC, Barber SA, Zink MC, (2008). Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1. J Neurovirol 14: 376-388.
    • (2008) J Neurovirol , vol.14 , pp. 376-388
    • Follstaedt, S.C.1    Barber, S.A.2    Zink, M.C.3
  • 37
    • 79951813085 scopus 로고    scopus 로고
    • The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties
    • Garrido-Mesa N, Camuesco D, Arribas B, Comalada M, Bailõn E, Cueto-Sola M, et al. (2011a). The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties. Pharmacol Res 63: 308-319.
    • (2011) Pharmacol Res , vol.63 , pp. 308-319
    • Garrido-Mesa, N.1    Camuesco, D.2    Arribas, B.3    Comalada, M.4    Bailõn, E.5    Cueto-Sola, M.6
  • 38
    • 80555149387 scopus 로고    scopus 로고
    • The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice
    • Garrido-Mesa N, Utrilla P, Comalada M, Zorrilla P, Garrido-Mesa J, Zarzuelo A, et al. (2011b). The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochem Pharmacol 82: 1891-1900.
    • (2011) Biochem Pharmacol , vol.82 , pp. 1891-1900
    • Garrido-Mesa, N.1    Utrilla, P.2    Comalada, M.3    Zorrilla, P.4    Garrido-Mesa, J.5    Zarzuelo, A.6
  • 39
    • 0027016532 scopus 로고
    • Tetracyclines (TCs) inhibit matrix metalloproteinases (MMPs): In vivo effects in arthritic and diabetic rats and new in vitro studies
    • Golub L, Greenwald R, Ramamurthy N, Zucker S, Ramsammy L, McNamara T, (1992). Tetracyclines (TCs) inhibit matrix metalloproteinases (MMPs): in vivo effects in arthritic and diabetic rats and new in vitro studies. Matrix Suppl 1: 315-316.
    • (1992) Matrix Suppl , vol.1 , pp. 315-316
    • Golub, L.1    Greenwald, R.2    Ramamurthy, N.3    Zucker, S.4    Ramsammy, L.5    McNamara, T.6
  • 40
    • 0021029655 scopus 로고
    • Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action
    • Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, et al. (1983). Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodont Res 18: 516-526.
    • (1983) J Periodont Res , vol.18 , pp. 516-526
    • Golub, L.M.1    Lee, H.M.2    Lehrer, G.3    Nemiroff, A.4    McNamara, T.F.5    Kaplan, R.6
  • 41
    • 0025875557 scopus 로고
    • Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs
    • Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR, (1991). Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2: 297-321.
    • (1991) Crit Rev Oral Biol Med , vol.2 , pp. 297-321
    • Golub, L.M.1    Ramamurthy, N.S.2    McNamara, T.F.3    Greenwald, R.A.4    Rifkin, B.R.5
  • 42
    • 33846215617 scopus 로고    scopus 로고
    • Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells
    • Gomes PS, Fernandes MH, (2007). Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells. Arch Oral Biol 52: 251-259.
    • (2007) Arch Oral Biol , vol.52 , pp. 251-259
    • Gomes, P.S.1    Fernandes, M.H.2
  • 43
    • 0041411243 scopus 로고    scopus 로고
    • Minocycline: Stain devil?
    • Good ML, Hussey DL, (2003). Minocycline: stain devil? Br J Dermatol 149: 237-239.
    • (2003) Br J Dermatol , vol.149 , pp. 237-239
    • Good, M.L.1    Hussey, D.L.2
  • 44
    • 36148960127 scopus 로고    scopus 로고
    • Efficacy of minocycline in patients with amyotrophic lateral sclerosis: A phase III randomised trial
    • Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, et al. (2007). Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6: 1045-1053.
    • (2007) Lancet Neurol , vol.6 , pp. 1045-1053
    • Gordon, P.H.1    Moore, D.H.2    Miller, R.G.3    Florence, J.M.4    Verheijde, J.L.5    Doorish, C.6
  • 45
    • 14644412903 scopus 로고    scopus 로고
    • Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo
    • Gourine AV, Molosh AI, Poputnikov D, Bulhak A, Sjöquist P-O, Pernow J, (2005). Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo. Br J Pharmacol 144: 331-337.
    • (2005) Br J Pharmacol , vol.144 , pp. 331-337
    • Gourine, A.V.1    Molosh, A.I.2    Poputnikov, D.3    Bulhak, A.4    Sjöquist, P.-O.5    Pernow, J.6
  • 46
    • 0027687395 scopus 로고
    • Tetracyclines in arthritis
    • Greenwald R, Golub LM, (1993). Tetracyclines in arthritis. J Rheumatol 20: 1990.
    • (1993) J Rheumatol , vol.20 , pp. 1990
    • Greenwald, R.1    Golub, L.M.2
  • 47
    • 80054111619 scopus 로고    scopus 로고
    • The road forward: The scientific basis for tetracycline treatment of arthritic disorders
    • Greenwald RA, (2011). The road forward: the scientific basis for tetracycline treatment of arthritic disorders. Pharmacol Res 64: 610-613.
    • (2011) Pharmacol Res , vol.64 , pp. 610-613
    • Greenwald, R.A.1
  • 49
    • 0026643124 scopus 로고
    • Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage
    • Greenwald RA, Moak SA, Ramamurthy NS, Golub LM, (1992). Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 19: 927-938.
    • (1992) J Rheumatol , vol.19 , pp. 927-938
    • Greenwald, R.A.1    Moak, S.A.2    Ramamurthy, N.S.3    Golub, L.M.4
  • 50
    • 77956562826 scopus 로고    scopus 로고
    • Tetracyclines: A pleitropic family of compounds with promising therapeutic properties. Review of the literature
    • Griffin MO, Fricovsky E, Ceballos G, Villarreal F, (2010). Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299: C539-C548.
    • (2010) Am J Physiol Cell Physiol , vol.299
    • Griffin, M.O.1    Fricovsky, E.2    Ceballos, G.3    Villarreal, F.4
  • 51
    • 33646439133 scopus 로고    scopus 로고
    • Activated microglia contribute to the maintenance of chronic pain after spinal cord injury
    • Hains BC, Waxman SG, (2006). Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26: 4308-4317.
    • (2006) J Neurosci , vol.26 , pp. 4308-4317
    • Hains, B.C.1    Waxman, S.G.2
  • 52
    • 0033634654 scopus 로고    scopus 로고
    • Regulated translation initiation controls stress-induced gene expression in mammalian cells
    • Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, et al. (2000). Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6: 1099-1108.
    • (2000) Mol Cell , vol.6 , pp. 1099-1108
    • Harding, H.P.1    Novoa, I.2    Zhang, Y.3    Zeng, H.4    Wek, R.5    Schapira, M.6
  • 53
    • 44949225039 scopus 로고    scopus 로고
    • Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
    • Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, et al. (2008). Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5: 15.
    • (2008) J Neuroinflammation , vol.5 , pp. 15
    • Henry, C.J.1    Huang, Y.2    Wynne, A.3    Hanke, M.4    Himler, J.5    Bailey, M.T.6
  • 54
    • 79955853282 scopus 로고    scopus 로고
    • Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: Results of a pilot study
    • Ho EL, Spudich SS, Lee E, Fuchs D, Sinclair E, Price RW, (2011). Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. AIDS Res Ther 8: 17.
    • (2011) AIDS Res Ther , vol.8 , pp. 17
    • Ho, E.L.1    Spudich, S.S.2    Lee, E.3    Fuchs, D.4    Sinclair, E.5    Price, R.W.6
  • 55
    • 0016588713 scopus 로고
    • Time course of 99mTc(Sn)-tetracycline uptake in experimental acute myocardial infarction
    • Holman BL, Zweiman FG, (1975). Time course of 99mTc(Sn)-tetracycline uptake in experimental acute myocardial infarction. J Nucl Med 16: 1144-1146.
    • (1975) J Nucl Med , vol.16 , pp. 1144-1146
    • Holman, B.L.1    Zweiman, F.G.2
  • 56
    • 0015838330 scopus 로고
    • Detection and localization of experimental myocardial infarction with 99m Tc-tetracycline
    • Holman BL, Idoine J, Fliegel CP, Davis MA, Treves S, Eldh P, et al. (1973). Detection and localization of experimental myocardial infarction with 99m Tc-tetracycline. J Nucl Med 14: 595-599.
    • (1973) J Nucl Med , vol.14 , pp. 595-599
    • Holman, B.L.1    Idoine, J.2    Fliegel, C.P.3    Davis, M.A.4    Treves, S.5    Eldh, P.6
  • 57
    • 77953543903 scopus 로고    scopus 로고
    • Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats
    • Hu X, Zhou X, He B, Xu C, Wu L, Cui B, et al. (2010). Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol 638: 84-89.
    • (2010) Eur J Pharmacol , vol.638 , pp. 84-89
    • Hu, X.1    Zhou, X.2    He, B.3    Xu, C.4    Wu, L.5    Cui, B.6
  • 58
    • 79951681007 scopus 로고    scopus 로고
    • Minocycline attenuates ischemia-induced ventricular arrhythmias in rats
    • Hu X, Wu B, Wang X, Xu C, He B, Cui B, et al. (2011). Minocycline attenuates ischemia-induced ventricular arrhythmias in rats. Eur J Pharmacol 654: 274-279.
    • (2011) Eur J Pharmacol , vol.654 , pp. 274-279
    • Hu, X.1    Wu, B.2    Wang, X.3    Xu, C.4    He, B.5    Cui, B.6
  • 59
    • 82255186386 scopus 로고    scopus 로고
    • Matrix metalloproteinases in tumorigenesis: An evolving paradigm
    • Hua H, Li M, Luo T, Yin Y, Jiang Y, (2011). Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci 68: 3853-3868.
    • (2011) Cell Mol Life Sci , vol.68 , pp. 3853-3868
    • Hua, H.1    Li, M.2    Luo, T.3    Yin, Y.4    Jiang, Y.5
  • 61
    • 67349085738 scopus 로고    scopus 로고
    • Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases
    • Huang T-Y, Chu H-C, Lin Y-L, Lin C-K, Hsieh T-Y, Chang W-K, et al. (2009b). Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Toxicol Appl Pharmacol 237: 69-82.
    • (2009) Toxicol Appl Pharmacol , vol.237 , pp. 69-82
    • Huang, T.-Y.1    Chu, H.-C.2    Lin, Y.-L.3    Lin, C.-K.4    Hsieh, T.-Y.5    Chang, W.-K.6
  • 63
    • 9144267928 scopus 로고    scopus 로고
    • Minocycline prevents cholinergic loss in a mouse model of Down's syndrome
    • Hunter CL, Bachman D, Granholm A-C, (2004). Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann Neurol 56: 675-688.
    • (2004) Ann Neurol , vol.56 , pp. 675-688
    • Hunter, C.L.1    Bachman, D.2    Granholm, A.-C.3
  • 64
    • 70450212126 scopus 로고    scopus 로고
    • Microglia and neuropathic pain
    • Inoue K, Tsuda M, (2009). Microglia and neuropathic pain. Glia 57: 1469-1479.
    • (2009) Glia , vol.57 , pp. 1469-1479
    • Inoue, K.1    Tsuda, M.2
  • 65
    • 66149134414 scopus 로고    scopus 로고
    • Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes
    • Ishikawa C, Tsuda T, Konishi H, Nakagawa N, Yamanishi K, (2009). Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes. Antimicrob Agents Chemother 53: 1760-1765.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1760-1765
    • Ishikawa, C.1    Tsuda, T.2    Konishi, H.3    Nakagawa, N.4    Yamanishi, K.5
  • 66
    • 80052848837 scopus 로고    scopus 로고
    • Effect of tetracyclines on IgE allergic responses and asthma
    • Joks R, Durkin HG, (2011a). Effect of tetracyclines on IgE allergic responses and asthma. Recent Pat Inflamm Allergy Drug Discov 5: 221-228.
    • (2011) Recent Pat Inflamm Allergy Drug Discov , vol.5 , pp. 221-228
    • Joks, R.1    Durkin, H.G.2
  • 67
    • 80054114660 scopus 로고    scopus 로고
    • Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs
    • Joks R, Durkin HG, (2011b). Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs. Pharmacol Res 64: 602-609.
    • (2011) Pharmacol Res , vol.64 , pp. 602-609
    • Joks, R.1    Durkin, H.G.2
  • 68
    • 77954065304 scopus 로고    scopus 로고
    • Tetracycline-mediated IgE isotype-specific suppression of ongoing human and murine IgE responses in vivo and murine memory IgE responses induced in vitro
    • Joks R, Smith-Norowitz T, Nowakowski M, Bluth MH, Durkin HG, (2010). Tetracycline-mediated IgE isotype-specific suppression of ongoing human and murine IgE responses in vivo and murine memory IgE responses induced in vitro. Int Immunol 22: 281-288.
    • (2010) Int Immunol , vol.22 , pp. 281-288
    • Joks, R.1    Smith-Norowitz, T.2    Nowakowski, M.3    Bluth, M.H.4    Durkin, H.G.5
  • 70
    • 7044270687 scopus 로고    scopus 로고
    • Minocycline inhibits antigen processing for presentation to human T cells: Additive inhibition with chloroquine at therapeutic concentrations
    • Kalish RS, Koujak S, (2004). Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations. Clin Immunol 113: 270-277.
    • (2004) Clin Immunol , vol.113 , pp. 270-277
    • Kalish, R.S.1    Koujak, S.2
  • 71
    • 35348910084 scopus 로고    scopus 로고
    • Minocycline modulates neuroinflammation independently of its antimicrobial activity in Staphylococcus aureus-induced brain abscess
    • Kielian T, Esen N, Liu S, Phulwani NK, Syed MM, Phillips N, et al. (2007). Minocycline modulates neuroinflammation independently of its antimicrobial activity in Staphylococcus aureus-induced brain abscess. Am J Pathol 171: 1199-1214.
    • (2007) Am J Pathol , vol.171 , pp. 1199-1214
    • Kielian, T.1    Esen, N.2    Liu, S.3    Phulwani, N.K.4    Syed, M.M.5    Phillips, N.6
  • 73
    • 0029866199 scopus 로고    scopus 로고
    • Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat
    • Klapisz-Wolikow M, Saffar JL, (1996). Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat. J Cell Physiol 167: 359-368.
    • (1996) J Cell Physiol , vol.167 , pp. 359-368
    • Klapisz-Wolikow, M.1    Saffar, J.L.2
  • 78
    • 0030609883 scopus 로고    scopus 로고
    • Altered gene expression in brain ischemia
    • Koistinaho J, Hökfelt T, (1997). Altered gene expression in brain ischemia. Neuroreport 8: i-viii.
    • (1997) Neuroreport , vol.8
    • Koistinaho, J.1    Hökfelt, T.2
  • 79
    • 17044364404 scopus 로고    scopus 로고
    • Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice
    • Koistinaho M, Malm TM, Kettunen MI, Goldsteins G, Starckx S, Kauppinen RA, et al. (2005). Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab 25: 460-467.
    • (2005) J Cereb Blood Flow Metab , vol.25 , pp. 460-467
    • Koistinaho, M.1    Malm, T.M.2    Kettunen, M.I.3    Goldsteins, G.4    Starckx, S.5    Kauppinen, R.A.6
  • 80
    • 67651174651 scopus 로고    scopus 로고
    • Current topical and systemic approaches to treatment of rosacea
    • Korting HC, Schöllmann C, (2009). Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 23: 876-882.
    • (2009) J Eur Acad Dermatol Venereol , vol.23 , pp. 876-882
    • Korting, H.C.1    Schöllmann, C.2
  • 81
    • 33845232989 scopus 로고    scopus 로고
    • Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome
    • Koukoui SD, Chaudhuri A, (2007). Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome. Brain Res Rev 53: 27-38.
    • (2007) Brain Res Rev , vol.53 , pp. 27-38
    • Koukoui, S.D.1    Chaudhuri, A.2
  • 82
    • 17844392902 scopus 로고    scopus 로고
    • Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy
    • Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, et al. (2005). Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54: 1559-1565.
    • (2005) Diabetes , vol.54 , pp. 1559-1565
    • Krady, J.K.1    Basu, A.2    Allen, C.M.3    Xu, Y.4    Lanoue, K.F.5    Gardner, T.W.6
  • 84
    • 23244453399 scopus 로고    scopus 로고
    • Antioxidant properties of minocycline: Neuroprotection in an oxidative stress assay and direct radical-scavenging activity
    • Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW, (2005). Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94: 819-827.
    • (2005) J Neurochem , vol.94 , pp. 819-827
    • Kraus, R.L.1    Pasieczny, R.2    Lariosa-Willingham, K.3    Turner, M.S.4    Jiang, A.5    Trauger, J.W.6
  • 85
    • 0036406903 scopus 로고    scopus 로고
    • Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis
    • Kriz J, Nguyen MD, Julien J-P, (2002). Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10: 268-278.
    • (2002) Neurobiol Dis , vol.10 , pp. 268-278
    • Kriz, J.1    Nguyen, M.D.2    Julien, J.-P.3
  • 86
    • 34848857092 scopus 로고    scopus 로고
    • Minocycline treatment in acute stroke: An open-label, evaluator-blinded study
    • Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, et al. (2007). Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69: 1404-1410.
    • (2007) Neurology , vol.69 , pp. 1404-1410
    • Lampl, Y.1    Boaz, M.2    Gilad, R.3    Lorberboym, M.4    Dabby, R.5    Rapoport, A.6
  • 87
    • 0034097452 scopus 로고    scopus 로고
    • Benefits and risks of minocycline in rheumatoid arthritis
    • Langevitz P, Livneh A, Bank I, Pras M, (2000). Benefits and risks of minocycline in rheumatoid arthritis. Drug Saf 22: 405-414.
    • (2000) Drug Saf , vol.22 , pp. 405-414
    • Langevitz, P.1    Livneh, A.2    Bank, I.3    Pras, M.4
  • 88
    • 79958729017 scopus 로고    scopus 로고
    • Minocycline injection in the ventral posterolateral thalamus reverses microglial reactivity and thermal hyperalgesia secondary to sciatic neuropathy
    • LeBlanc BW, Zerah ML, Kadasi LM, Chai N, Saab CY, (2011). Minocycline injection in the ventral posterolateral thalamus reverses microglial reactivity and thermal hyperalgesia secondary to sciatic neuropathy. Neurosci Lett 498: 138-142.
    • (2011) Neurosci Lett , vol.498 , pp. 138-142
    • Leblanc, B.W.1    Zerah, M.L.2    Kadasi, L.M.3    Chai, N.4    Saab, C.Y.5
  • 89
    • 17044417657 scopus 로고    scopus 로고
    • Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation
    • Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, et al. (2005). Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115: 71-83.
    • (2005) Pain , vol.115 , pp. 71-83
    • Ledeboer, A.1    Sloane, E.M.2    Milligan, E.D.3    Frank, M.G.4    Mahony, J.H.5    Maier, S.F.6
  • 90
    • 0034647003 scopus 로고    scopus 로고
    • Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
    • Li M, Ona VO, Guégan C, Chen M, Jackson-Lewis V, Andrews LJ, et al. (2000). Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288: 335-339.
    • (2000) Science , vol.288 , pp. 335-339
    • Li, M.1    Ona, V.O.2    Guégan, C.3    Chen, M.4    Jackson-Lewis, V.5    Andrews, L.J.6
  • 91
    • 79551520334 scopus 로고    scopus 로고
    • Minocycline inhibits the growth of glioma by inducing autophagy
    • Liu W-T, Lin C-H, Hsiao M, Gean P-W, (2011). Minocycline inhibits the growth of glioma by inducing autophagy. Autophagy 7: 166-175.
    • (2011) Autophagy , vol.7 , pp. 166-175
    • Liu, W.-T.1    Lin, C.-H.2    Hsiao, M.3    Gean, P.-W.4
  • 92
    • 79251636716 scopus 로고    scopus 로고
    • Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers
    • Lokeshwar BL, (2011). Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers. Pharmacol Res 63: 146-150.
    • (2011) Pharmacol Res , vol.63 , pp. 146-150
    • Lokeshwar, B.L.1
  • 94
    • 22044453675 scopus 로고    scopus 로고
    • The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes
    • Macfarlane SR, Sloss CM, Cameron P, Kanke T, McKenzie RC, Plevin R, (2005). The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes. Br J Pharmacol 145: 535-544.
    • (2005) Br J Pharmacol , vol.145 , pp. 535-544
    • Macfarlane, S.R.1    Sloss, C.M.2    Cameron, P.3    Kanke, T.4    McKenzie, R.C.5    Plevin, R.6
  • 95
  • 96
    • 79954741725 scopus 로고    scopus 로고
    • Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression
    • Markovic DS, Vinnakota K, van, Rooijen N, Kiwit J, Synowitz M, Glass R, et al. (2011). Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain Behav Immun 25: 624-628.
    • (2011) Brain Behav Immun , vol.25 , pp. 624-628
    • Markovic, D.S.1    Van, V.K.2    Rooijen, N.3    Kiwit, J.4    Synowitz, M.5    Glass, R.6
  • 97
    • 0028203567 scopus 로고
    • Inhibitory effect of minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma
    • Masumori N, Tsukamoto T, Miyao N, Kumamoto Y, Saiki I, Yoneda J, (1994). Inhibitory effect of minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma. J Urol 151: 1400-1404.
    • (1994) J Urol , vol.151 , pp. 1400-1404
    • Masumori, N.1    Tsukamoto, T.2    Miyao, N.3    Kumamoto, Y.4    Saiki, I.5    Yoneda, J.6
  • 98
    • 79957600105 scopus 로고    scopus 로고
    • Post-injury administration of minocycline: An effective treatment for nerve-injury induced neuropathic pain
    • Mei X-P, Xu H, Xie C, Ren J, Zhou Y, Zhang H, et al. (2011). Post-injury administration of minocycline: an effective treatment for nerve-injury induced neuropathic pain. Neurosci Res 70: 305-312.
    • (2011) Neurosci Res , vol.70 , pp. 305-312
    • Mei, X.-P.1    Xu, H.2    Xie, C.3    Ren, J.4    Zhou, Y.5    Zhang, H.6
  • 99
    • 11144354138 scopus 로고    scopus 로고
    • Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis
    • Metz LM, Zhang Y, Yeung M, Patry DG, Bell RB, Stoian CA, et al. (2004). Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 55: 756.
    • (2004) Ann Neurol , vol.55 , pp. 756
    • Metz, L.M.1    Zhang, Y.2    Yeung, M.3    Patry, D.G.4    Bell, R.B.5    Stoian, C.A.6
  • 100
    • 72449159325 scopus 로고    scopus 로고
    • Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: Results of a Canadian, multicenter, double-blind, placebo-controlled trial
    • Metz LM, Li D, Traboulsee A, Myles ML, Duquette P, Godin J, et al. (2009). Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. Mult Scler 15: 1183-1194.
    • (2009) Mult Scler , vol.15 , pp. 1183-1194
    • Metz, L.M.1    Li, D.2    Traboulsee, A.3    Myles, M.L.4    Duquette, P.5    Godin, J.6
  • 101
    • 33847417406 scopus 로고    scopus 로고
    • Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain
    • Mika J, Osikowicz M, Makuch W, Przewlocka B, (2007). Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 560: 142-149.
    • (2007) Eur J Pharmacol , vol.560 , pp. 142-149
    • Mika, J.1    Osikowicz, M.2    Makuch, W.3    Przewlocka, B.4
  • 102
    • 0032198174 scopus 로고    scopus 로고
    • Chemical and biological dynamics of tetracyclines
    • Nelson ML, (1998). Chemical and biological dynamics of tetracyclines. Adv Dent Res 12: 5-11.
    • (1998) Adv Dent Res , vol.12 , pp. 5-11
    • Nelson, M.L.1
  • 103
    • 0036830527 scopus 로고    scopus 로고
    • Effect of minocycline in experimental autoimmune encephalomyelitis
    • author reply 690
    • Nessler S, Dodel R, Bittner A, Reuss S, Du Y, Hemmer B, et al. (2002). Effect of minocycline in experimental autoimmune encephalomyelitis. Ann Neurol 52: 689-690; author reply 690.
    • (2002) Ann Neurol , vol.52 , pp. 689-690
    • Nessler, S.1    Dodel, R.2    Bittner, A.3    Reuss, S.4    Du, Y.5    Hemmer, B.6
  • 104
    • 33644876641 scopus 로고    scopus 로고
    • Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IκBα degradation in a stimulus-specific manner in microglia
    • Nikodemova M, Duncan ID, Watters JJ, (2006). Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IκBα degradation in a stimulus-specific manner in microglia. J Neurochem 96: 314-323.
    • (2006) J Neurochem , vol.96 , pp. 314-323
    • Nikodemova, M.1    Duncan, I.D.2    Watters, J.J.3
  • 105
    • 34447540331 scopus 로고    scopus 로고
    • Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)/betaII
    • Nikodemova M, Watters JJ, Jackson SJ, Yang SK, Duncan ID, (2007). Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)/betaII. J Biol Chem 282: 15208-15216.
    • (2007) J Biol Chem , vol.282 , pp. 15208-15216
    • Nikodemova, M.1    Watters, J.J.2    Jackson, S.J.3    Yang, S.K.4    Duncan, I.D.5
  • 106
    • 51349109618 scopus 로고    scopus 로고
    • The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice
    • Niu G, Liao Z, Cai L, Wei R, Sun L, (2008). The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice. Cancer Biother Radiopharm 23: 469-476.
    • (2008) Cancer Biother Radiopharm , vol.23 , pp. 469-476
    • Niu, G.1    Liao, Z.2    Cai, L.3    Wei, R.4    Sun, L.5
  • 107
    • 65349135346 scopus 로고    scopus 로고
    • Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
    • O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, et al. (2009). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511-522.
    • (2009) Mol Psychiatry , vol.14 , pp. 511-522
    • O'Connor, J.C.1    Lawson, M.A.2    André, C.3    Moreau, M.4    Lestage, J.5    Castanon, N.6
  • 108
    • 0033587128 scopus 로고    scopus 로고
    • Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
    • Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, et al. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399: 263-267.
    • (1999) Nature , vol.399 , pp. 263-267
    • Ona, V.O.1    Li, M.2    Vonsattel, J.P.3    Andrews, L.J.4    Khan, S.Q.5    Chung, W.M.6
  • 109
    • 33746354314 scopus 로고    scopus 로고
    • Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn
    • Owolabi SA, Saab CY, (2006). Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn. FEBS Lett 580: 4306-4310.
    • (2006) FEBS Lett , vol.580 , pp. 4306-4310
    • Owolabi, S.A.1    Saab, C.Y.2
  • 110
    • 79956200772 scopus 로고    scopus 로고
    • Minocycline attenuates the development of diabetic neuropathic pain: Possible anti-inflammatory and anti-oxidant mechanisms
    • Pabreja K, Dua K, Sharma S, Padi SSV, Kulkarni SK, (2011). Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. Eur J Pharmacol 661: 15-21.
    • (2011) Eur J Pharmacol , vol.661 , pp. 15-21
    • Pabreja, K.1    Dua, K.2    Sharma, S.3    Padi, S.S.V.4    Kulkarni, S.K.5
  • 112
    • 79957933723 scopus 로고    scopus 로고
    • Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice
    • Park CH, Shin TK, Lee HY, Kim SJ, Lee WS, (2011). Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol 15: 115.
    • (2011) Korean J Physiol Pharmacol , vol.15 , pp. 115
    • Park, C.H.1    Shin, T.K.2    Lee, H.Y.3    Kim, S.J.4    Lee, W.S.5
  • 114
    • 33745539802 scopus 로고    scopus 로고
    • Use of antibiotics in the treatment of inflammatory bowel disease
    • Perencevich M, Burakoff R, (2006). Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 12: 651-664.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 651-664
    • Perencevich, M.1    Burakoff, R.2
  • 115
    • 0141642017 scopus 로고    scopus 로고
    • Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury
    • Pinney SP, Chen HJ, Liang D, Wang X, Schwartz A, Rabbani LE, (2003). Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury. J Cardiovasc Pharmacol 42: 469-476.
    • (2003) J Cardiovasc Pharmacol , vol.42 , pp. 469-476
    • Pinney, S.P.1    Chen, H.J.2    Liang, D.3    Wang, X.4    Schwartz, A.5    Rabbani, L.E.6
  • 118
    • 0037622717 scopus 로고    scopus 로고
    • Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy
    • Raghavendra V, Tanga F, DeLeo Joyce A, (2003). Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306: 624-630.
    • (2003) J Pharmacol Exp Ther , vol.306 , pp. 624-630
    • Raghavendra, V.1    Tanga, F.2    Deleo Joyce, A.3
  • 119
    • 77956416346 scopus 로고    scopus 로고
    • Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS
    • Ratai E-M, Bombardier JP, Joo C-G, Annamalai L, Burdo TH, Campbell J, et al. (2010). Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. Plos ONE 5: e10523.
    • (2010) Plos ONE , vol.5
    • Ratai, E.-M.1    Bombardier, J.P.2    Joo, C.-G.3    Annamalai, L.4    Burdo, T.H.5    Campbell, J.6
  • 120
    • 0031959973 scopus 로고    scopus 로고
    • Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size
    • Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC, (1998). Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29: 1020-1030.
    • (1998) Stroke , vol.29 , pp. 1020-1030
    • Romanic, A.M.1    White, R.F.2    Arleth, A.J.3    Ohlstein, E.H.4    Barone, F.C.5
  • 122
    • 80555157650 scopus 로고    scopus 로고
    • Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trial
    • Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, et al. (2011). Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology 77: 1135-1142.
    • (2011) Neurology , vol.77 , pp. 1135-1142
    • Sacktor, N.1    Miyahara, S.2    Deng, L.3    Evans, S.4    Schifitto, G.5    Cohen, B.A.6
  • 123
    • 40849126421 scopus 로고    scopus 로고
    • Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat
    • Saganová K, Orendácová J, Cízková D, Vanický I, (2008). Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat. Neurosci Lett 433: 246-249.
    • (2008) Neurosci Lett , vol.433 , pp. 246-249
    • Saganová, K.1    Orendácová, J.2    Cízková, D.3    Vanický, I.4
  • 124
    • 1542510038 scopus 로고    scopus 로고
    • Doxycycline and other tetracyclines in the treatment of bone metastasis
    • Saikali Z, Singh G, (2003). Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs 14: 773-778.
    • (2003) Anticancer Drugs , vol.14 , pp. 773-778
    • Saikali, Z.1    Singh, G.2
  • 125
    • 0024271676 scopus 로고
    • Clinical pharmacokinetics of doxycycline and minocycline
    • Saivin S, Houin G, (1988). Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 15: 355-366.
    • (1988) Clin Pharmacokinet , vol.15 , pp. 355-366
    • Saivin, S.1    Houin, G.2
  • 126
    • 0034998271 scopus 로고    scopus 로고
    • Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction
    • discussion 1399-1401
    • Sanchez Mejia RO, Ona VO, Li M, Friedlander RM, (2001). Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48: 1393-1399; discussion 1399-1401.
    • (2001) Neurosurgery , vol.48 , pp. 1393-1399
    • Sanchez Mejia, R.O.1    Ona, V.O.2    Li, M.3    Friedlander, R.M.4
  • 127
    • 31344476048 scopus 로고    scopus 로고
    • Tetracyclines: Nonantibiotic properties and their clinical implications
    • Sapadin AN, Fleischmajer R, (2006). Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54: 258-265.
    • (2006) J Am Acad Dermatol , vol.54 , pp. 258-265
    • Sapadin, A.N.1    Fleischmajer, R.2
  • 128
    • 10744226569 scopus 로고    scopus 로고
    • Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO
    • Scarabelli TM, Stephanou A, Pasini E, Gitti G, Townsend P, Lawrence K, et al. (2004). Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol 43: 865-874.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 865-874
    • Scarabelli, T.M.1    Stephanou, A.2    Pasini, E.3    Gitti, G.4    Townsend, P.5    Lawrence, K.6
  • 129
    • 47949120118 scopus 로고    scopus 로고
    • Clinical use of E. coli Nissle 1917 in inflammatory bowel disease
    • Schultz M, (2008). Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis 14: 1012-1018.
    • (2008) Inflamm Bowel Dis , vol.14 , pp. 1012-1018
    • Schultz, M.1
  • 130
    • 33646243562 scopus 로고    scopus 로고
    • Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice
    • Seabrook TJ, Jiang L, Maier M, Lemere CA, (2006). Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 53: 776-782.
    • (2006) Glia , vol.53 , pp. 776-782
    • Seabrook, T.J.1    Jiang, L.2    Maier, M.3    Lemere, C.A.4
  • 131
    • 80054978002 scopus 로고    scopus 로고
    • Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1)
    • Shahzad K, Thati M, Wang H, Kashif M, Wolter J, Ranjan S, et al. (2011). Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1). Atherosclerosis 219: 74-83.
    • (2011) Atherosclerosis , vol.219 , pp. 74-83
    • Shahzad, K.1    Thati, M.2    Wang, H.3    Kashif, M.4    Wolter, J.5    Ranjan, S.6
  • 132
    • 7244257593 scopus 로고    scopus 로고
    • A novel action of minocycline: Inhibition of human immunodeficiency virus type 1 infection in microglia
    • Si Q, Cosenza M, Kim M-O, Zhao M-L, Brownlee M, Goldstein H, et al. (2004). A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. J Neurovirol 10: 284-292.
    • (2004) J Neurovirol , vol.10 , pp. 284-292
    • Si, Q.1    Cosenza, M.2    Kim, M.-O.3    Zhao, M.-L.4    Brownlee, M.5    Goldstein, H.6
  • 133
    • 80052289615 scopus 로고    scopus 로고
    • Neural circuit architecture defects in a Drosophila model of fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase
    • Siller SS, Broadie K, (2011). Neural circuit architecture defects in a Drosophila model of fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase. Dis Models Mech 4: 673-685.
    • (2011) Dis Models Mech , vol.4 , pp. 673-685
    • Siller, S.S.1    Broadie, K.2
  • 135
    • 61849088368 scopus 로고    scopus 로고
    • A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: A literature review
    • Soory M, (2008). A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review. Open Dent J 2: 5-12.
    • (2008) Open Dent J , vol.2 , pp. 5-12
    • Soory, M.1
  • 137
    • 1542376941 scopus 로고    scopus 로고
    • Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury
    • Stirling DP, (2004). Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24: 2182-2190.
    • (2004) J Neurosci , vol.24 , pp. 2182-2190
    • Stirling, D.P.1
  • 139
    • 0141642241 scopus 로고    scopus 로고
    • Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity
    • Stone M, Fortin PR, Pacheco-Tena C, Inman RD, (2003). Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol 30: 2112-2122.
    • (2003) J Rheumatol , vol.30 , pp. 2112-2122
    • Stone, M.1    Fortin, P.R.2    Pacheco-Tena, C.3    Inman, R.D.4
  • 141
    • 33644760497 scopus 로고    scopus 로고
    • Effects of minocycline and doxycycline on cell survival and gene expression in human gingival and periodontal ligament cells
    • Suzuki A, Yagisawa J, Kumakura S, Tsutsui T, (2006). Effects of minocycline and doxycycline on cell survival and gene expression in human gingival and periodontal ligament cells. J Periodont Res 41: 124-131.
    • (2006) J Periodont Res , vol.41 , pp. 124-131
    • Suzuki, A.1    Yagisawa, J.2    Kumakura, S.3    Tsutsui, T.4
  • 142
    • 77950258687 scopus 로고    scopus 로고
    • Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells
    • Szeto GL, Brice AK, Yang H, Barber SA, Siliciano RF, Clements JE, (2010). Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells. J Infect Dis 201: 1132-1140.
    • (2010) J Infect Dis , vol.201 , pp. 1132-1140
    • Szeto, G.L.1    Brice, A.K.2    Yang, H.3    Barber, S.A.4    Siliciano, R.F.5    Clements, J.E.6
  • 143
    • 78751643428 scopus 로고    scopus 로고
    • Minocycline protects cardiac myocytes against simulated ischemia-reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1
    • Tao R, Kim SH, Honbo N, Karliner JS, Alano CC, (2010). Minocycline protects cardiac myocytes against simulated ischemia-reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1. J Cardiovasc Pharmacol 56: 659-668.
    • (2010) J Cardiovasc Pharmacol , vol.56 , pp. 659-668
    • Tao, R.1    Kim, S.H.2    Honbo, N.3    Karliner, J.S.4    Alano, C.C.5
  • 144
    • 25144474888 scopus 로고    scopus 로고
    • PKR and eIF2alpha: Integration of kinase dimerization, activation, and substrate docking
    • Taylor SS, Haste NM, Ghosh G, (2005). PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking. Cell 122: 823-825.
    • (2005) Cell , vol.122 , pp. 823-825
    • Taylor, S.S.1    Haste, N.M.2    Ghosh, G.3
  • 145
    • 12144290904 scopus 로고    scopus 로고
    • Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury
    • Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, et al. (2004). Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 101: 3071-3076.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 3071-3076
    • Teng, Y.D.1    Choi, H.2    Onario, R.C.3    Zhu, S.4    Desilets, F.C.5    Lan, S.6
  • 146
    • 1442326012 scopus 로고    scopus 로고
    • Minocycline: Neuroprotective mechanisms in Parkinson's disease
    • Thomas M, Le WD, (2004). Minocycline: neuroprotective mechanisms in Parkinson's disease. Curr Pharm Des 10: 679-686.
    • (2004) Curr Pharm des , vol.10 , pp. 679-686
    • Thomas, M.1    Le, W.D.2
  • 147
    • 4444233214 scopus 로고    scopus 로고
    • Minocycline in Huntington's disease: A pilot study
    • Thomas M, Ashizawa T, Jankovic J, (2004). Minocycline in Huntington's disease: a pilot study. Mov Disord 19: 692-695.
    • (2004) Mov Disord , vol.19 , pp. 692-695
    • Thomas, M.1    Ashizawa, T.2    Jankovic, J.3
  • 148
    • 0035871840 scopus 로고    scopus 로고
    • Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
    • Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J, (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588.
    • (2001) J Neurosci , vol.21 , pp. 2580-2588
    • Tikka, T.1    Fiebich, B.L.2    Goldsteins, G.3    Keinanen, R.4    Koistinaho, J.5
  • 149
    • 0036209082 scopus 로고    scopus 로고
    • Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease
    • Tikka TM, Vartiainen NE, Goldsteins G, Oja SS, Andersen PM, Marklund SL, et al. (2002). Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 125: 722-731.
    • (2002) Brain , vol.125 , pp. 722-731
    • Tikka, T.M.1    Vartiainen, N.E.2    Goldsteins, G.3    Oja, S.S.4    Andersen, P.M.5    Marklund, S.L.6
  • 150
    • 0028888687 scopus 로고
    • Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group
    • Tilley BC, Alarcõn GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, et al. (1995). Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med 122: 81-89.
    • (1995) Ann Intern Med , vol.122 , pp. 81-89
    • Tilley, B.C.1    Alarcõn, G.S.2    Heyse, S.P.3    Trentham, D.E.4    Neuner, R.5    Kaplan, D.A.6
  • 151
    • 2342538502 scopus 로고    scopus 로고
    • Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system
    • Tomás-Camardiel M, Rite I, Herrera AJ, de, Pablos RM, Cano J, Machado A, et al. (2004). Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 16: 190-201.
    • (2004) Neurobiol Dis , vol.16 , pp. 190-201
    • Tomás-Camardiel, M.1    Rite, I.2    De Herrera, A.J.3    Pablos, R.M.4    Cano, J.5    Machado, A.6
  • 153
    • 0037067009 scopus 로고    scopus 로고
    • Minocycline delays disease onset and mortality in a transgenic model of ALS
    • Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W, (2002). Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13: 1067-1070.
    • (2002) Neuroreport , vol.13 , pp. 1067-1070
    • Van Den Bosch, L.1    Tilkin, P.2    Lemmens, G.3    Robberecht, W.4
  • 154
    • 0036897794 scopus 로고    scopus 로고
    • The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs
    • Végh A, Parratt JR, (2002). The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs. Br J Pharmacol 137: 1107-1115.
    • (2002) Br J Pharmacol , vol.137 , pp. 1107-1115
    • Végh, A.1    Parratt, J.R.2
  • 155
    • 20544468364 scopus 로고    scopus 로고
    • Minocycline inhibits LPS-induced retinal microglia activation
    • Wang AL, Yu ACH, Lau LT, Lee C, Wu LM, Zhu X, et al. (2005). Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 47: 152-158.
    • (2005) Neurochem Int , vol.47 , pp. 152-158
    • Wang, A.L.1    Yu, A.C.H.2    Lau, L.T.3    Lee, C.4    Wu, L.M.5    Zhu, X.6
  • 156
    • 0041335559 scopus 로고    scopus 로고
    • Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease
    • Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, et al. (2003). Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci U S A 100: 10483-10487.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 10483-10487
    • Wang, X.1    Zhu, S.2    Drozda, M.3    Zhang, W.4    Stavrovskaya, I.G.5    Cattaneo, E.6
  • 157
    • 0037481943 scopus 로고    scopus 로고
    • Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice
    • Wells JEA, Hurlbert RJ, Fehlings MG, Yong VW, (2003). Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126: 1628-1637.
    • (2003) Brain , vol.126 , pp. 1628-1637
    • Wells, J.E.A.1    Hurlbert, R.J.2    Fehlings, M.G.3    Yong, V.W.4
  • 158
    • 0020395586 scopus 로고
    • Characterization of chlortetracycline (aureomycin) as a calcium ionophore
    • White JR, Pearce FL, (1982). Characterization of chlortetracycline (aureomycin) as a calcium ionophore. Biochemistry 21: 6309-6312.
    • (1982) Biochemistry , vol.21 , pp. 6309-6312
    • White, J.R.1    Pearce, F.L.2
  • 159
    • 0031018687 scopus 로고    scopus 로고
    • Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics
    • Whiteman M, Halliwell B, (1997). Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics. Free Radic Res 26: 49-56.
    • (1997) Free Radic Res , vol.26 , pp. 49-56
    • Whiteman, M.1    Halliwell, B.2
  • 160
    • 57049115325 scopus 로고    scopus 로고
    • Minocycline attenuates nitric oxide-mediated neuronal and axonal destruction in vitro
    • Wilkins A, Nikodemova M, Compston A, Duncan I, (2004). Minocycline attenuates nitric oxide-mediated neuronal and axonal destruction in vitro. Neuron Glia Biol 1: 297-305.
    • (2004) Neuron Glia Biol , vol.1 , pp. 297-305
    • Wilkins, A.1    Nikodemova, M.2    Compston, A.3    Duncan, I.4
  • 161
    • 0016278688 scopus 로고
    • Minocycline: Possible vestibular side-effects
    • Williams D, Laughlin L, Lee Y-H, (1974). Minocycline: possible vestibular side-effects. Lancet 304: 744-746.
    • (1974) Lancet , vol.304 , pp. 744-746
    • Williams, D.1    Laughlin, L.2    Lee, Y.-H.3
  • 162
    • 0030446143 scopus 로고    scopus 로고
    • Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats
    • Williams S, Wakisaka A, Zeng QQ, Barnes J, Martin G, Wechter WJ, et al. (1996). Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone 19: 637-644.
    • (1996) Bone , vol.19 , pp. 637-644
    • Williams, S.1    Wakisaka, A.2    Zeng, Q.Q.3    Barnes, J.4    Martin, G.5    Wechter, W.J.6
  • 164
    • 0036522967 scopus 로고    scopus 로고
    • Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease
    • Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, et al. (2002). Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22: 1763-1771.
    • (2002) J Neurosci , vol.22 , pp. 1763-1771
    • Wu, D.C.1    Jackson-Lewis, V.2    Vila, M.3    Tieu, K.4    Teismann, P.5    Vadseth, C.6
  • 165
    • 77749264306 scopus 로고    scopus 로고
    • Improving outcomes of neuroprotection by minocycline: Guides from cell culture and intracerebral hemorrhage in mice
    • Xue M, Mikliaeva EI, Casha S, Zygun D, Demchuk A, Yong VW, (2010). Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice. Am J Pathol 176: 1193-1202.
    • (2010) Am J Pathol , vol.176 , pp. 1193-1202
    • Xue, M.1    Mikliaeva, E.I.2    Casha, S.3    Zygun, D.4    Demchuk, A.5    Yong, V.W.6
  • 167
    • 4143127785 scopus 로고    scopus 로고
    • Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: The role of ERK1/2, PI3K, and matrix metalloproteinases
    • Yao JS, Chen Y, Zhai W, Xu K, Young WL, Yang G-Y, (2004). Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 95: 364-371.
    • (2004) Circ Res , vol.95 , pp. 364-371
    • Yao, J.S.1    Chen, Y.2    Zhai, W.3    Xu, K.4    Young, W.L.5    Yang, G.-Y.6
  • 168
    • 33645799230 scopus 로고    scopus 로고
    • Microglia potentiate damage to blood-brain barrier constituents: Improvement by minocycline in vivo and in vitro
    • Yenari MA, Xu L, Tang XN, Qiao Y, Giffard RG, (2006). Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37: 1087-1093.
    • (2006) Stroke , vol.37 , pp. 1087-1093
    • Yenari, M.A.1    Xu, L.2    Tang, X.N.3    Qiao, Y.4    Giffard, R.G.5
  • 170
    • 0037038402 scopus 로고    scopus 로고
    • The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
    • Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, et al. (2002). The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420: 78-84.
    • (2002) Nature , vol.420 , pp. 78-84
    • Youssef, S.1    Stüve, O.2    Patarroyo, J.C.3    Ruiz, P.J.4    Radosevich, J.L.5    Hur, E.M.6
  • 172
    • 0033539522 scopus 로고    scopus 로고
    • A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window
    • Yrjänheikki J, Tikka T, Keinänen R, Goldsteins G, Chan PH, Koistinaho J, (1999). A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96: 13496-13500.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 13496-13500
    • Yrjänheikki, J.1    Tikka, T.2    Keinänen, R.3    Goldsteins, G.4    Chan, P.H.5    Koistinaho, J.6
  • 173
    • 0037067317 scopus 로고    scopus 로고
    • Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor
    • Yu S-W, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. (2002). Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263.
    • (2002) Science , vol.297 , pp. 259-263
    • Yu, S.-W.1    Wang, H.2    Poitras, M.F.3    Coombs, C.4    Bowers, W.J.5    Federoff, H.J.6
  • 174
    • 34447643571 scopus 로고    scopus 로고
    • Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury
    • Yune TY, Lee JY, Jung GY, Kim SJ, Jiang MH, Kim YC, et al. (2007). Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27: 7751-7761.
    • (2007) J Neurosci , vol.27 , pp. 7751-7761
    • Yune, T.Y.1    Lee, J.Y.2    Jung, G.Y.3    Kim, S.J.4    Jiang, M.H.5    Kim, Y.C.6
  • 175
    • 34249039892 scopus 로고    scopus 로고
    • The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: A pilot study
    • Zabad RK, Metz LM, Todoruk TR, Zhang Y, Mitchell JR, Yeung M, et al. (2007). The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult Scler 13: 517-526.
    • (2007) Mult Scler , vol.13 , pp. 517-526
    • Zabad, R.K.1    Metz, L.M.2    Todoruk, T.R.3    Zhang, Y.4    Mitchell, J.R.5    Yeung, M.6
  • 176
    • 11244317215 scopus 로고    scopus 로고
    • The potential of minocycline for neuroprotection in human neurologic disease
    • Zemke D, Majid A, (2004). The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 27: 293-298.
    • (2004) Clin Neuropharmacol , vol.27 , pp. 293-298
    • Zemke, D.1    Majid, A.2
  • 177
    • 0030857355 scopus 로고    scopus 로고
    • Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis
    • Zernicke RF, Wohl GR, Greenwald RA, Moak SA, Leng W, Golub LM, (1997). Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis. J Rheumatol 24: 1324-1331.
    • (1997) J Rheumatol , vol.24 , pp. 1324-1331
    • Zernicke, R.F.1    Wohl, G.R.2    Greenwald, R.A.3    Moak, S.A.4    Leng, W.5    Golub, L.M.6
  • 178
    • 0028726067 scopus 로고
    • Changes of monoamines, purines and amino acids in rat striatum as measured by intercerebral microdialysis during ischemia/reperfusion
    • Zhang J, Niu X, (1994). Changes of monoamines, purines and amino acids in rat striatum as measured by intercerebral microdialysis during ischemia/reperfusion. Chin Med Sci J 9: 225-229.
    • (1994) Chin Med Sci J , vol.9 , pp. 225-229
    • Zhang, J.1    Niu, X.2
  • 179
    • 0037007645 scopus 로고    scopus 로고
    • Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
    • Zhu S, Stavrovskaya IG, Drozda M, Kim BYS, Ona V, Li M, et al. (2002). Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417: 74-78.
    • (2002) Nature , vol.417 , pp. 74-78
    • Zhu, S.1    Stavrovskaya, I.G.2    Drozda, M.3    Kim, B.Y.S.4    Ona, V.5    Li, M.6
  • 180
    • 79960883074 scopus 로고    scopus 로고
    • Neuronal and microglial mechanisms of neuropathic pain
    • Zhuo M, Wu G, Wu L-J, (2011). Neuronal and microglial mechanisms of neuropathic pain. Mol Brain 4: 31.
    • (2011) Mol Brain , vol.4 , pp. 31
    • Zhuo, M.1    Wu, G.2    Wu, L.-J.3
  • 181
    • 17544370486 scopus 로고    scopus 로고
    • Neuroprotective and anti-human immunodeficiency virus activity of minocycline
    • Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, et al. (2005). Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293: 2003-2011.
    • (2005) JAMA , vol.293 , pp. 2003-2011
    • Zink, M.C.1    Uhrlaub, J.2    Dewitt, J.3    Voelker, T.4    Bullock, B.5    Mankowski, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.